Who should not receive Sandostatin LAR?

Advertisement
Advertisement
Children should not receive Sandostatin LAR. The safety and effectiveness of this drug has not been established in children under six years of age. Studies in older children and adolescents showed a higher risk for gallbladder problems. If you are allergic to any of the ingredients in the octreotide injection, you should not receive Sandostatin LAR. Tell your doctor about any allergies you may have, including a latex allergy, before starting treatment with Sandostatin LAR.

Continue Learning about Endocrine-Metabolic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.